Latvia is the second largest Baltic country with an area of some 25,100 square miles and a population of 2 million people. It became a EU member state in 2004, and its regulatory and legislative environment was stepwise synchronized with the European legislation.
CMEC (Central Medical Ethics committee of Latvia) is the central and the most important element of the regulatory system. CMEC is governed by Cabinet Regulation No. 9 “Statutes of Central Medical Ethics Committee”, issued in 1998. The conduct of clinical trials in the Republic of Latvia is regulated by the Cabinet of Ministers Regulation No. 289 of 23 March 2010.